SCHEMBL95186

SCHEMBL95186

[CH2]C=CCc1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.70
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
ARG2 P78540 1/20 0.52
TOP1 P11387 1/20 0.42
CALM1 P0DP23 1/20 0.41
MAPK1 P28482 1/20 0.39
IDO1 P14902 2/20 0.39
TSHR P16473 3/20 0.38
ALDH1A1 P00352 2/20 0.38
TP53 P04637 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
TRPA1 O75762 1/20 0.38
AGXT P21549 1/20 0.37
KCNH2 Q12809 2/20 0.37
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
CASP1 P29466 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL95185 1.00 MAOB (0.70) MAOBCA1CA2ARG2TOP1
SCHEMBL9110389 0.83 MAOB (0.61) MAOBCA1CA2ARG2TOP1
SCHEMBL9110392 0.83 MAOB (0.61) MAOBCA1CA2ARG2TOP1
SCHEMBL155055 0.83 MAOB (1.00) MAOBCA1CA2ARG2TOP1
SCHEMBL155054 0.83 MAOB (1.00) MAOBCA1CA2ARG2TOP1
SCHEMBL1524697 0.83 MAOB (1.00) MAOBCA1CA2ARG2TOP1
SCHEMBL9063783 0.81 LTA4H (0.52) MAOBCA1CA2TSHR
SCHEMBL628859 0.78 MAOB (0.78) MAOBCA1CA2ARG2TOP1
Allylbenzene SCHEMBL833722 0.78
SCHEMBL462351 0.78 MAOB (0.78) MAOBCA1CA2ARG2TOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 826 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109748841-B Method for catalyzing asymmetric synthesis of chiral beta-aminoketone derivative 浙江工业大学 2021-06-01 CN claimed
EP-1653960-A4 MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST AMGEN INC (US) 2008-11-26 EP claimed
EP-1654225-A4 MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONISTS AMGEN INC (US) 2007-11-28 EP claimed
EP-1653960-A2 MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST AMGEN INC. (US) 2006-05-10 EP claimed
EP-1654225-A2 MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONISTS Amgen, Inc. (US) 2006-05-10 EP claimed
EP-0831812-B1 METHODS AND COMPOSITIONS FOR STIMULATING NEURITE GROWTH VERTEX PHARMA (US) 2005-12-07 EP claimed
US-20050256161-A1 Melanin concentrating hormone receptor antagonists AMGEN INC. 2005-11-17 US claimed
US-20050215526-A1 Melanin concentrating hormone receptor antagonist AMGEN, INC. 2005-09-29 US claimed
WO-2005019240-A2 MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONISTS AMGEN, INC. (US) 2005-03-03 WO claimed
WO-2005019167-A2 MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST AMGEN, INC. (US) 2005-03-03 WO claimed
US-5990044-A Selective herbicides based on aryl uracils BAYER AKTIENGESELLSCHAFT (DE) 1999-11-23 US claimed
EP-0786938-A1 SELECTIVE HERBICIDES BASED ON CARBAMOYLTRIAZOLINONES AND HETEROARYLOXYACETAMIDES BAYER AG (DE) 1997-08-06 EP claimed
EP-0778732-A1 SELECTIVE HERBICIDES BASED ON ARYL URACILS BAYER AG (DE) 1997-06-18 EP claimed
EP-0319986-B1 Anti-plasmin depressant NIPPON SHINYAKU CO LTD (JP) 1997-03-12 EP claimed
WO-1996011575-A1 SELECTIVE HERBICIDES BASED ON CARBAMOYLTRIAZOLINONES AND HETEROARYLOXYACETAMIDES BAYER AKTIENGESELLSCHAFT (DE) 1996-04-25 WO claimed
WO-1996007323-A1 SELECTIVE HERBICIDES BASED ON ARYL URACILS BAYER AKTIENGESELLSCHAFT (DE) 1996-03-14 WO claimed
US-5276008-A Herbicides and plant growth regulators BAYER AKTIENGESELLSCHAFT (DE) 1994-01-04 US claimed
EP-0205834-B1 7-THIABICYCLOHEPTANE SUBSTITUTED ETHERS E.R. Squibb & Sons, Inc. (US) 1990-10-31 EP claimed
US-4410730-A Process for the production of o-(N-monosubstituted amino)benzyl alcohols SHIONOGI & CO., LTD. (JP) 1983-10-18 US claimed
US-4198503-A 3-Carbamoyl substituted-7-ureido substituted cephalosporins BEECHAM GROUP LIMITED (GB) 1980-04-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215526-A1 Melanin concentrating hormone receptor antagonist MCHR1, MC1R, NPY1R MAOB 133/4885CA1 4513/4885CA2 4272/4885
US-20050256161-A1 Melanin concentrating hormone receptor antagonists MCHR1, MC1R, NPY1R MAOB 70/4885CA1 4129/4885CA2 3746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.